Earkart Limited
₹125.35▲ +0.00 (+0.00%)
EARKART·BSE·Healthcare
Market Cap
172.41 Cr
PE Ratio
35.01
Volume
10,000
Day High - Low
125.35 - 125.35
52W High-Low
221.25 - 104.35
₹125.35▲ +0.00 (+0.00%)
Market Cap172.41 Cr
PE Ratio35.01
Volume10,000
Day High - Low125.35 - 125.35
52W High-Low221.25 - 104.35
Earkart Limited (EARKART): company summary
The company's annual revenue rose 25.4% to ₹54 crore, but annual net profit fell 28.2% to ₹5 crore.
Earkart Limited (EARKART) is a micro-cap Healthcare company valued at ₹172 crore operating in Medical Equipment on the NSE and BSE.
- Recent price move
- Earkart Limited last traded at ₹125.35, unchanged on the day.
- Financial performance
- The company's annual revenue rose 25.4% to ₹54 crore, but annual net profit fell 28.2% to ₹5 crore. The latest quarter revenue was ₹32 crore, up from ₹24 crore in the prior year quarter, while net profit was ₹3 crore, down from ₹3 crore in the same quarter a year earlier. The net profit margin narrowed 6.8 percentage points to 9.1%.
- Valuation multiples
- The stock trades at 35.0 times earnings, broadly in line with the Healthcare median of 32.0, 2.94 times book value.
- Things to watch
- The company's net profit margin fell 6.8 percentage points to 9.1%, and the stock is 43.3% below its 52-week high. The latest quarter net profit was ₹3 crore, down from ₹3 crore in the same quarter a year earlier.
- Where it stands
- The company's revenue grew 25.4% annually, but net profit dropped 28.2% year-on-year. The latest quarter net profit was ₹3 crore, flat compared to the same quarter a year earlier. The stock is 43.3% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
7.68%
Weak
P/E
35.01x
Expensive
Debt / Equity
0.00
Low
Industry
Healthcare
Medical Equipment
Overall View
Mixed
Price performance
52W₹104.35
₹221.25
DocStoX take
Supported by growth (8.5) and risk (6.5), but held back by momentum (0.4). Growth looks strong at 8.5, but that is offset by momentum at 0.4 and valuation at 1.5. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.3
/10
Weak
Quality
Modest
ROE 7.7%
Valuation
Expensive
P/E 35.0×
Growth
Strong
Revenue +23.2% 3Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Weak
18% of 52-week range
At a glance
Market Cap
₹172 Cr
52W High / Low
₹221 / ₹104
Dividend Yield
0.00%
Promoter Holding
57.34%
EPS (TTM)
₹3.58
Book Value
₹46.79
Key highlights
- Profit compounding 56% a year
- Low leverage — D/E 0.00
- Profitable in all of the last 5 years
- Valuation is weak (1.5/10)
- Momentum is weak (0.4/10)
4 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Medical Equipment
Explore Earkart Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Earkart Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedCipla LimitedDr. Reddy's Laboratories LimitedMankind Pharma LimitedAurobindo Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Earkart Limited with peers
Related tools & concepts
Value Earkart Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing